JAN 18, 2017 6:01 PM PST

A Cup of Coffee Could Help Chronic Inflammation

WRITTEN BY: Jennifer Ellis

Stanford researchers have uncovered an association between the aging process, chronic inflammation that can come with aging, cardiovascular disease risk, and a good old cup of coffee.

The multiyear study, published in Nature Medicine, followed 100 participants through blood samples, surveys, and medical and family history. By in-depth genetic and epidemiological analysis of study data, the group identified several correlating health factors with caffeine as well as a common inflammatory mechanism that was active in a subset of the participants that had low caffeine intake and suppressed in those that regularly drank coffee.

Coffee tends to lessen effects of inflammatory pathways

Chronic inflammation is known to become more prevalent with age. It is also one of the main causes of a host of age-related diseases, such as many cancers, Alzheimer’s disease and other dementias, cardiovascular disease, osteoarthritis and even depression. The fact that the study shows a direct correlation between chronic inflammation pathways and cardiovascular risk further supports previous findings.

“More than 90 percent of all noncommunicable diseases of aging are associated with chronic inflammation,” said the study’s lead author, David Furman, PhD, a consulting associate professor at the Stanford Institute for Immunity, Transplantation and Infection, “It’s also well-known that caffeine intake is associated with longevity. Many studies have shown this association. We’ve found a possible reason for why this may be so.”

Researchers compared blood drawn in older vs younger participants to figure out if there were any immune-related genes that were more active in older people and thus potentially associated with aging. They focused on two gene clusters that are connected to the activity of a specific circulating inflammatory protein called IL-1-beta. The IL-1-beta protein an important mediator of the inflammatory response, and is involved in various cellular activities, including cell proliferation, differentiation, and apoptosis. IL-1-beta is also found to contribute to inflammatory pain hypersensitivity, and its surrounding process is implicated in cardiovascular disease and overall mortality.

IL-1-beta tends to be triggered by metabolites, breakdown products from nucleic acids, circulating in the blood. The findings showed that the effects of these metabolites were countered by caffeine and its metabolites.

Looking further into what associations the gene clusters have within the group of participants, the team found several other unique differences. Within the older group of participants, those that had high activation of one or both gene clusters also had high blood pressure, were less likely to live to 90, had increased activity of free radicals and had elevated levels of both IL-1-beta and circulating metabolites.

In order to confirm these associations, the team incubated immune cells with certain metabolites and tested gene cluster and IL-1-beta activity. As expected, the metabolites caused an increase in activity in one of the gene clusters, resulting in increased IL-1-beta production. The team then injected the metabolites into mice, which caused severe systemic inflammation and increased blood pressure.

Returning to the premise of the involvement of caffeine in the correlations between older participants’ health and gene-cluster activation, the researchers confirmed that blood taken from the healthier group with low cluster activity was enriched for caffeine and its metabolites. Adding caffeine and its breakdown products to immune cells along with the original nucleic acid metabolites prevented the metabolites from causing the same severe inflammatory effect on the cells.

“That something many people drink — and actually like to drink — might have a direct benefit came as a surprise to us,” said Davis. “What we’ve shown is a correlation between caffeine consumption and longevity. And we’ve shown more rigorously, in laboratory tests, a very plausible mechanism for why this might be so.”

Sources: Stanford News, Nature Medicine

About the Author
  • I love all things science and am passionate about bringing science to the public through writing. With an M.S. in Genetics and experience in cancer research, marketing and technical writing, it is a pleasure to share the latest trends and findings in science on LabRoots.
You May Also Like
AUG 05, 2020
Immunology
Intercepting Cancer Cells Before They Can Dodge the Immune System
AUG 05, 2020
Intercepting Cancer Cells Before They Can Dodge the Immune System
The battle that naturally occurs between the body’s immune system and cancerous cells is one that scientists have ...
SEP 28, 2020
Genetics & Genomics
Why Some Young, Healthy People Get Severe COVID-19
SEP 28, 2020
Why Some Young, Healthy People Get Severe COVID-19
Since the start of the pandemic, scientists have been trying to find out why some people get such severe illness from SA ...
OCT 08, 2020
Immunology
Immuno Metabolic Complexity and Modulating Metabolites
OCT 08, 2020
Immuno Metabolic Complexity and Modulating Metabolites
Immunometabolism is a relatively new subspecialty of immunology as we’ve begun to unravel the complex metabolic re ...
NOV 04, 2020
Coronavirus
Damaging Antibodies Can Lead to Blood Clots in COVID-19 Patients
NOV 04, 2020
Damaging Antibodies Can Lead to Blood Clots in COVID-19 Patients
COVID-19, the illness caused by the pandemic virus SARS-CoV-2, is known to cause blood clots all over the body in some p ...
NOV 06, 2020
Immunology
The Coronavirus Is No Match Against Sybody 23
NOV 06, 2020
The Coronavirus Is No Match Against Sybody 23
The virus that causes COVID-19, SARS-CoV-2, uses its spike protein to gain access to cells, by binding to the ACE2 recep ...
NOV 10, 2020
Neuroscience
Nanoparticles Pass the Blood-Brain Barrier in Zebrafish
NOV 10, 2020
Nanoparticles Pass the Blood-Brain Barrier in Zebrafish
Video:  Explains the challenges of delivering medicine to the brain, and possibly tools to pass the blood-brain bar ...
Loading Comments...